HIGHLIGHTS
- who: Shiro Komiya from the Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan have published the research work: Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial, in the Journal: (JOURNAL)
- what: This prospective randomized controlled study was designed to compare the effects of TLV addition versus increased FUR dose in advanced CKD patients. Fourth, since it is also interested in the long-term cardioprotective effect of TLV, but the authors cannot find the answer because this study examines the short . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.